These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6287349)

  • 21. Possible role of distinct morphine and enkephalin receptors in mediating actins of benzomorphan drugs (putative kappa and sigma agonists).
    Chang KJ; Hazum E; Cuatrecasas P
    Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4469-73. PubMed ID: 6254028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The irreversible narcotic antagonistic and reversible agonistic properties of the fumaramate methyl ester derivative of naltrexone.
    Takemori AE; Larson DL; Portoghese PS
    Eur J Pharmacol; 1981 Apr; 70(4):445-51. PubMed ID: 6263637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective protection of stereospecific enkephalin and opiate binding against inactivation by N-ethylmaleimide: evidence for two classes of opiate receptors.
    Smith JR; Simon EJ
    Proc Natl Acad Sci U S A; 1980 Jan; 77(1):281-4. PubMed ID: 6244551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Examination of the involvement of supraspinal and spinal mu and delta opioid receptors in analgesia using the mu receptor deficient CXBK mouse.
    Vaught JL; Mathiasen JR; Raffa RB
    J Pharmacol Exp Ther; 1988 Apr; 245(1):13-6. PubMed ID: 2834533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of beta-FNA on opiate receptor binding: preliminary evidence for two types of mu receptors.
    Rothman RB; Bowen WD; Schumacher UK; Pert CB
    Eur J Pharmacol; 1983 Nov; 95(1-2):147-8. PubMed ID: 6321203
    [No Abstract]   [Full Text] [Related]  

  • 26. Neurochemical and functional correlates of naltrexone-induced opiate receptor up-regulation.
    Tempel A; Gardner EL; Zukin RS
    J Pharmacol Exp Ther; 1985 Feb; 232(2):439-44. PubMed ID: 2982011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analgesia induced by electroconvulsive shock: brain enkephalins may mediate tolerance but not the induction of analgesia.
    Urca G; Nof A; Weissman BA; Sarne Y
    Brain Res; 1983 Feb; 260(2):271-7. PubMed ID: 6299458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonopioidergic mechanism mediating morphine-induced antianalgesia in the mouse spinal cord.
    Wu HE; Thompson J; Sun HS; Leitermann RJ; Fujimoto JM; Tseng LF
    J Pharmacol Exp Ther; 2004 Jul; 310(1):240-6. PubMed ID: 14999057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Binding of a new opiate antagonist, nalmefene, to rat brain membranes.
    Michel ME; Bolger G; Weissman BA
    Methods Find Exp Clin Pharmacol; 1985 Apr; 7(4):175-7. PubMed ID: 2991678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Action at the mu receptor is sufficient to explain the supraspinal analgesic effect of opiates.
    Fang FG; Fields HL; Lee NM
    J Pharmacol Exp Ther; 1986 Sep; 238(3):1039-44. PubMed ID: 3018217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of morphinone on opiate receptor binding and morphine-elicited analgesia.
    Nagamatsu K; Kido Y; Terao T; Ishida T; Toki S
    Life Sci; 1982 Oct; 31(14):1451-7. PubMed ID: 6183553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. beta-FNA binds irreversibly to the opiate receptor complex: in vivo and in vitro evidence.
    Rothman RB; Long JB; Bykov V; Jacobson AE; Rice KC; Holaday JW
    J Pharmacol Exp Ther; 1988 Nov; 247(2):405-16. PubMed ID: 2846819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Irreversible opiate agonists and antagonists. III. Phenylhydrazone derivatives of naloxone and oxymorphone.
    Hahn EF; Itzhak Y; Nishimura S; Johnson N; Pasternak GW
    J Pharmacol Exp Ther; 1985 Dec; 235(3):846-50. PubMed ID: 2416910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Naloxazone pretreatment modifies cardiorespiratory, temperature, and behavioral effects of morphine.
    Holaday JW; Pasternak GW; Faden AI
    Neurosci Lett; 1983 Jun; 37(2):199-204. PubMed ID: 6308526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An increase in opiate receptor-sites is associated with enhanced cardiovascular depressant, but not respiratory depressant action of morphine.
    Pfeiffer A; Pfeiffer DG; Feuerstein G; Faden AI; Kopin IJ
    Brain Res; 1984 Apr; 296(2):305-11. PubMed ID: 6322927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paradoxical analgesia produced by low doses of the opiate-antagonist naloxone is mediated by interaction at a site with characteristics of the delta opioid receptor.
    Taiwo YO; Basbaum AI; Perry F; Levine JD
    J Pharmacol Exp Ther; 1989 Apr; 249(1):97-100. PubMed ID: 2540325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Naloxonazine actions in vivo.
    Ling GS; Simantov R; Clark JA; Pasternak GW
    Eur J Pharmacol; 1986 Sep; 129(1-2):33-8. PubMed ID: 3021478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Naloxone rapidly evokes endogenous kappa opioid receptor-mediated hyperalgesia in naïve mice pretreated briefly with GM1 ganglioside or in chronic morphine-dependent mice.
    Crain SM; Shen KF
    Brain Res; 2007 Sep; 1167():31-41. PubMed ID: 17692296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of receptor mechanism mediating fentanyl analgesia and toxicity.
    Jang Y; Yoburn BC
    Eur J Pharmacol; 1991 May; 197(2-3):135-41. PubMed ID: 1655470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delta but not mu-opioid receptors in the spinal cord are involved in antinociception induced by beta-endorphin given intracerebroventricularly in mice.
    Suh HH; Tseng LF
    J Pharmacol Exp Ther; 1990 Jun; 253(3):981-6. PubMed ID: 2162954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.